Accepted Manuscript New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease Irina Zueva, José Dias, Sofya Lushchekina, Vyacheslav Semenov, Marat Mukhamedyarov, Tatiana Pashirova, Vasiliy Babaev, Florian Nachon, Natalia Petrova, Leniz Nurullin, Lucia Zakharova, Victor Ilyin, Patrick Masson, Konstantin Petrov PII: S0028-3908(18)30519-7 DOI: https://doi.org/10.1016/j.neuropharm.2019.05.025 Reference: NP 7648 To appear in: Neuropharmacology Received Date: 17 August 2018 Revised Date: 6 May 2019 Accepted Date: 19 May 2019 Please cite this article as: Zueva, I., Dias, José., Lushchekina, S., Semenov, V., Mukhamedyarov, M., Pashirova, T., Babaev, V., Nachon, F., Petrova, N., Nurullin, L., Zakharova, L., Ilyin, V., Masson, P., Petrov, K., New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease, Neuropharmacology (2019), doi: https://doi.org/10.1016/ j.neuropharm.2019.05.025. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.